Integrated Filing- Financial

Here's a summary of Anlon Healthcare Limited's financial results: **1. Financial Performance:** Consolidated revenue from operations stood at ₹508.89 Cr for the full year, a significant increase from ₹355.78 Cr in the previous year.

This growth was driven by the company's core business of manufacturing and selling Active Pharmaceutical Ingredients (APIs). **2. Profitability and EPS:** The company reported a consolidated profit after tax of ₹110.72 Cr for the full year, a notable improvement from ₹51.52 Cr in the prior year.

Diluted EPS for the year rose to ₹5.15 from ₹1.13 in the previous year. **3. Growth Drivers & Expense Trends:** Revenue expansion appears to be the primary driver of the improved profitability.

While overall expenses increased, they were outpaced by the revenue growth. **4. Final Lens for Investors:** The company is demonstrating strong financial momentum with substantial revenue and profit growth.